Status:
COMPLETED
Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers
Lead Sponsor:
Pfizer
Conditions:
Methodology Study
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
This study will assess the feasibility of conducting sleep studies in a clinical research unit environment. In addition, the sensitivity of polysomnography and mobile actigraphy technologies will be c...
Eligibility Criteria
Inclusion
- Age 18-55
- BMI 18-30 kg/m2
- body weight \> 50 kg
Exclusion
- no history of sleep disorder
- no concurrent medications
- no alcohol use
- no medical issues
- no smoking
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00716521
Start Date
July 1 2008
End Date
October 1 2008
Last Update
April 24 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
New Haven, Connecticut, United States, 06511